have identified that exosomal DACT3-AS1, originating from cancer-associated fibroblasts (CAFs), functions as a suppressor in gastric cancer (GC) by impeding malignant transformation and oxaliplatin resistance. This evidence concerns the gene DACT3 and gastric cancer.